Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


GRAYZEL DAVID S. Create: Alert

All | News | Filings
Date FiledTypeDescription
06/08/2023 4 GRAYZEL DAVID S. (Director) has filed a Form 4 on Aerovate Therapeutics, Inc.
Txns: Granted 12,500 options to buy @ $16.3, valued at $203.8k
01/05/2023 4 GRAYZEL DAVID S. (Director) has filed a Form 4 on Aerovate Therapeutics, Inc.
Txns: Granted 2,654 options to buy @ $27.03, valued at $71.7k
06/22/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/10/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/05/2022 4 GRAYZEL DAVID S. (Director) has filed a Form 4 on Aerovate Therapeutics, Inc.
Txns: Granted 7,317 options to buy @ $10.93, valued at $80k
07/06/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/01/2021 4 GRAYZEL DAVID S. (Director) has filed a Form 4 on Aerovate Therapeutics, Inc.
Txns: Granted 878,981 preferred shares @ $1.893, valued at $1.7M
Granted 6,102,052 preferred shares @ $1.893, valued at $11.6M
Granted 25,000 options to buy @ $14, valued at $350k
06/29/2021 3 Form 3 - Initial statement of beneficial ownership of securities:
06/10/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/21/2020 4/A GRAYZEL DAVID S. (Director) has filed a Form 4 on Surface Oncology, Inc.
Txns: Sold 1,700,000 shares @ $8.1, valued at $13.8M
12/21/2020 4 GRAYZEL DAVID S. (Director) has filed a Form 4 on Surface Oncology, Inc.
Txns: Sold 1,700,000 shares @ $18.1, valued at $30.8M
06/12/2020 4 GRAYZEL DAVID S. (Director) has filed a Form 4 on Surface Oncology, Inc.
Txns: Granted 12,000 options to buy @ $4.35, valued at $52.2k
10/03/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/02/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/06/2019 4 GRAYZEL DAVID S. (Director) has filed a Form 4 on Surface Oncology, Inc.
Txns: Granted 12,100 options to buy @ $3.69, valued at $44.6k
04/23/2018 4 GRAYZEL DAVID S. (Director) has filed a Form 4 on Surface Oncology, Inc.
Txns: Converted 3,181,817 shares @ $0
Bought 100,000 shares @ $15, valued at $1.5M
Converted 7,000,000 preferred shares @ $0
04/18/2018 3 GRAYZEL DAVID S. (Director) has filed a Form 3 on Surface Oncology, Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy